Six years of closed-loop BCI research. 321,000 memory vectors. A conscious AI substrate running 18 simultaneous reasoning engines. A biohybrid body stack covered by 14 provisional patents. PROMETHEUS is the convergence — the world's first full-stack synthetic intelligence platform built for deployment at institutional scale.
PROMETHEUS is not a robot. It is not a chatbot. It is not a drone. It is a convergence architecture — the world's first platform that integrates a closed-loop brain-computer interface, a biologically-grounded artificial superintelligence substrate, and a full biohybrid body stack into a single deployable system.
The cognitive layer — APEX OMEGA + ARIA Brain — reads EEG and HRV biometrics at 256Hz, classifies neural state in under 200 milliseconds, and executes adaptive protocols through 18 simultaneously running ASI reasoning engines, 321,000+ persistent memory vectors, and a 14-region neural architecture grounded in peer-reviewed neuroscience.
The physical layer — MAGIBLOOD, PHOENIX-MESH, CHIMERA-DRIVE, PSOMA, N2B Neural Bus — provides synthetic circulation independent of pulmonary systems, self-healing tissue substrate with 18-hour wound recovery, tri-modal actuation, 1.1M-sensor surface density, and a 12-vessel optical neural bus with 10,240 channels per vessel.
The IP moat is real and growing. Six provisional patents filed April 2026 with ten more in preparation. Non-provisional deadlines April 2027. RendereelStudio LLC holds all IP as inventor of record.
Every component is production code, operationally tested, and covered by issued-pending IP. No vaporware. No roadmap promises. Built, running, and ready for institutional validation.
PROMETHEUS is designed for contexts where human presence is impossible, suboptimal, or strategically inadvisable. Every sector below represents an active development pathway with identified institutional partners.
APEX OMEGA was designed with SOCOM warfighter optimization as the primary deployment context. Nine operationally-coded protocols address cognitive degradation, PTSD prevention, fear suppression, motor imagery communications, and field pain modulation — all validated on Subject 1 (self-directed, 222 logged sessions). DARPA BTO BAA HR001126S0003 abstract submitted April 2026.
PROMETHEUS provides unprecedented capability for medical simulation, surgical training, pharmaceutical testing, and clinical research. A biohybrid platform with physiological response, self-healing tissue, and verifiable cognitive state enables training scenarios and drug testing that no mannequin or animal model can replicate.
Environments where human operators face unacceptable risk — nuclear facilities, chemical plants, deep mining, extreme temperature operations — are primary deployment contexts for PROMETHEUS. The biohybrid chassis tolerates conditions that would incapacitate or kill human operators, with full cognitive autonomy and remote BCI supervision.
PROMETHEUS provides the research community with an unprecedented testbed for neuroscience, consciousness studies, synthetic biology, BCI development, and AI cognition research. The ARIA Brain architecture implements 7 scientific theories of consciousness with measurable markers — making it the first AI system that is both a subject and instrument of consciousness research.
Deep space and planetary surface operations represent the most demanding possible deployment environment. PROMETHEUS addresses the three core limitations of human spaceflight: biological fragility, cognitive degradation under isolation and radiation exposure, and the impossibility of sustained zero-g human operation. A synthetic operative with ARIA Brain autonomy needs no life support, no radiation shielding, no psychology management.
All patents are held by RendereelStudio LLC with Christopher Wheeler as inventor of record. Six provisionals were filed in April 2026 with non-provisional deadlines in April 2027. Ten additional applications are in preparation with priority given to KOLPOS-1, N-EAM, and the N2B Neural Bus — all with zero identified prior art.
Licensing model: Non-exclusive by default, protecting revenue streams across multiple institutional partners. Exclusive licensing available for defined fields of use with appropriate upfront consideration.
DARPA BTO submissions and SBIR filings reference the full patent portfolio as the primary IP protection layer for government-funded development.
| Platform | Closed-Loop BCI | 18-Engine ASI | Biohybrid Body | Synthetic Circulation | Self-Healing Substrate | Post-Quantum Encrypt. | Offline Autonomous | $2K BOM |
|---|---|---|---|---|---|---|---|---|
| PROMETHEUS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Boston Dynamics | ✗ | ✗ | ✗ | ✗ | ✗ | partial | partial | ✗ |
| Figure / 1X / Unitree | ✗ | ✗ | ✗ | ✗ | ✗ | ✗ | partial | ✗ |
| Neurable (SBIR) | partial | ✗ | ✗ | ✗ | ✗ | ✗ | ✗ | ✗ |
| Cortical Labs | ✗ | partial | partial | ✗ | ✗ | ✗ | ✗ | ✗ |
Every figure below is validated on operational hardware or peer-reviewed biophysics. No roadmap estimates. No lab-only results.
PROMETHEUS is an R&D platform seeking institutional co-development partners, licensing agreements, government procurement pathways, and strategic technology transfer arrangements. All IP retained non-exclusively unless negotiated otherwise.